Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization

被引：3

作者：

Nilsson, Magnus ^{[1
]}

Berggren, Kristina ^{[1
]}

Berglund, Susanne ^{[1
]}

Cerboni, Silvia ^{[2
]}

Collins, Mia ^{[2
]}

Dahl, Goran ^{[3
]}

Elmqvist, David ^{[4
]}

Grimster, Neil P. ^{[5
]}

Hendrickx, Ramon ^{[6
]}

Johansson, Johan R. ^{[1
]}

Kettle, Jason G. ^{[5
]}

Lepisto, Matti ^{[1
]}

Rhedin, Magdalena ^{[2
]}

Smailagic, Amir ^{[2
]}

Su, Qibin ^{[5
]}

Wennberg, Tiiu ^{[2
]}

Wu, Allan ^{[7
]}

Osterlund, Torben ^{[8
]}

Naessens, Thomas ^{[2
]}

Mitra, Suman ^{[2
]}

机构：

[1] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Med Chem Res & Early Dev, SE-43183 Gothenburg, Sweden

[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biosci Res & Early Dev, SE-43183 Gothenburg, Sweden

[3] AstraZeneca, BioPharmaceut R&D, Struct & Biophys Res & Early Dev, Discovery Sci, SE-43183 Gothenburg, Sweden

[4] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Prod Dev, SE-43183 Gothenburg, Sweden

[5] AstraZeneca R&D, Oncol R&D, Waltham, MA 02451 USA

[6] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Resp & Immunol,DMPK, SE-43183 Gothenburg, Sweden

[7] AstraZeneca R&D, Discovery Sci, R&D, Waltham, MA 02451 USA

[8] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Discovery Sci,Mechanist Biol & Profiling, SE-43183 Gothenburg, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年

关键词：

T-CELLS; TISSUE DISTRIBUTION; JAK1; INHIBITORS; IMMUNITY; IDENTIFICATION; MECHANISMS;

D O I：

10.1021/acs.jmedchem.3c00554

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

JAK-STAT cytokines are critical in regulating immunity. Persistent activation of JAK-STAT signaling pathways by cytokines drives chronic inflammatory diseases such as asthma. Herein, we report on the discovery of a highly JAK1-selective, ATP-competitive series of inhibitors having a 1000-fold selectivity over other JAK family members and the approach used to identify compounds suitable for inhaled administration. Ultimately, compound 16 was selected as the clinical candidate, and upon dry powder inhalation, we could demonstrate a high local concentration in the lung as well as low plasma concentrations, suggesting no systemic JAK1 target engagement. Compound 16 has progressed into clinical trials. Using 16, we found JAK1 inhibition to be more efficacious than JAK3 inhibition in IL-4-driven Th2 asthma.

引用

页码：13400 / 13415

页数：16

共 50 条

[1] Inhaled AZD4604: Local Janus Kinase 1 Inhibition Without Systemic Activity
Riff, C.
Larsson, J.
Nilsson, M.
Hasselberg, A.
Gurcan, E.
Konstantinidis, K. V.
Hughes, R.
Delaney, S.
Dosanjh, D. P.
Hedstrom, U.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[2] Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor
Pithani, Subhash
Aurell, Carl-Johan
Lindhagen, Marika
Nunn, Michael
Berggren, Kristina
Emtenas, Hans
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (07) : 1317 - 1329
[3] AZD4604, An Inhaled, Selective JAK1 Inhibitor Reduces Fractional Exhaled Nitric Oxide in Patients with Mild Asthma; A Randomized, Single-Blind Phase 1 Study
Jensen, Tina Jellesmark
Larsson, Julia
Maenpaa, Jukka
Mo, John
Nemes, Szilard
Riff, Camille
Rojnik, Zala Jevnikar
Zingmark, Pernilla
Konstantinidis, Kyriakos
Belvisi, Maria
Keen, Christina
Soto, Pablo Forte
Chetty, Rajkumar
Singh, Dave
Hughes, Rod
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB98 - AB98
[4] Discovery of a potent and selective Axl inhibitor in preclinical model
Inoue, Satoshi
Yamane, Yoshinobu
Tsukamoto, Shuntaro
Azuma, Hiroshi
Nagao, Satoshi
Murai, Norio
Nishibata, Kyoko
Fukushima, Sayo
Ichikawa, Kenji
Nakagawa, Takayuki
Sugi, Naoko Hata
Ito, Daisuke
Kato, Yu
Goto, Aya
Kakiuchi, Dai
Ueno, Takashi
Matsui, Junji
Matsushima, Tomohiro
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 39
[5] Discovery of the JAK1 selective kinase inhibitor AZD4205
Kettle, Jason G.
Su, Qibin
Grimster, Neil
Kawatkar, Sameer
Throner, Scott
Woessner, Richard
Chen, Huawei
Bebernitz, Geraldine
Bell, Kristen
Anderson, Erica
Ruston, Linette
Winter-Holt, Jon
Lyne, Paul
Vasbinder, Melissa
Chuaqui, Claudio
CANCER RESEARCH, 2017, 77
[6] Discovery of the JAK1 selective kinase inhibitor AZD4205
Su, Qibin
Kettle, Jason
Grimster, Neil
Vasbinder, Melissa
Kawatkar, Sameer
Throner, Scott
Woessner, Rich
Chen, Huawei
Chuaqui, Claudio
Bebernitz, Geraldine
Bell, Kristen
Anderson, Erica Anderson
Ruston, Linette
Winter-Holt, Jon
Yang, Wenzhan
Lyne, Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[7] Discovery of a potent and selective Aurora kinase inhibitor
Oslob, Johan D.
Romanowski, Michael J.
Allen, Darin A.
Baskaran, Subramanian
Bui, Minna
Elling, Robert A.
Flanagan, William M.
Fung, Amy D.
Hanan, Emily J.
Harris, Shannon
Heumann, Stacey A.
Hoch, Ute
Jacobs, Jeffrey W.
Lam, Joni
Lawrence, Chris E.
McDowell, Robert S.
Nannini, Michelle A.
Shen, Wang
Silverman, Jeffrey A.
Sopko, Michelle M.
Tangonan, Bradley T.
Teague, Juli
Yoburn, Josh C.
Yu, Chul H.
Zhong, Min
Zimmerman, Kristin M.
O'Brien, Tom
Lew, Willard
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4880 - 4884
[8] Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
Hanan, Emily J.
van Abbema, Anne
Barrett, Kathy
Blair, Wade S.
Blaney, Jeff
Chang, Christine
Eigenbrot, Charles
Flynn, Sean
Gibbons, Paul
Hurley, Christopher A.
Kenny, Jane R.
Kulagowski, Janusz
Lee, Leslie
Magnuson, Steven R.
Morris, Claire
Murray, Jeremy
Pastor, Richard M.
Rawson, Tom
Siu, Michael
Ultsch, Mark
Zhou, Aihe
Sampath, Deepak
Lyssikatos, Joseph P.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10090 - 10107
[9] Characterization of AZD8055, a potent selective inhibitor of mTORC1 and mTORC2 kinase
Chresta, Christine
Davies, Barry
Harding, Tom
Hickson, Ian
Cosulich, Sabina
Critchlow, Susan
Sini, Patrizia
James, Dominic
Malagu, Karine
Hummersone, Marc
Smith, Graeme
Pass, Martin
Guichard, Sylvie
CANCER RESEARCH, 2009, 69
[10] Discovery and Characterization of a Potent and Selective Inhibitor for Human Phosphoinositide-3-kinase γ
Meleza, Cesar
Chen, Ada
Fournier, Jeremy
Mailyan, Artur
Mata, Guillaume
Jeffrey, Jenna
Banuelos, Jesus
Zhao, Xiaoning
Leleti, Manmohan
Jin, Lixia
Powers, Jay
Matthew, J.
Young, Stephen
FASEB JOURNAL, 2020, 34

← 1 2 3 4 5 →